Asian insurers recoil from structured products

Institutional and regulatory barriers blamed for poor take-up of derivatives by life companies

Life insurers in Hong Kong are conservative

Asian insurers are put off investing in structured products by a deep-seated suspicion of the asset class among their boards of directors and by high regulatory capital charges, delegates heard at the Structured Products Asia conference in Hong Kong.

Recommending such investments can even be a career risk for employees, according to one speaker.

Board members still remember the heavy losses some of the region's insurance companies suffered on their portfolios of collateralised debt obligations

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: